RIP kinases and necroptosis in aging and aging-related diseases

被引：11

作者：

Yang, Yuanxin ^{[1
,2
]}

Li, Xingyan ^{[1
]}

Zhang, Tao ^{[3
]}

Xu, Daichao ^{[1
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China

[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China

[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA

来源：

LIFE MEDICINE | 2022年 / 1卷 / 01期

基金：

中国博士后科学基金; 国家重点研发计划;

关键词：

RIPK1; RIPK3; necroptosis; aging; inflammation; NF-KAPPA-B; TOLL-LIKE RECEPTORS; INTERACTING PROTEIN KINASE-3; MIXED LINEAGE KINASE; CELL-DEATH; PROGRAMMED NECROSIS; INTERSTITIAL FIBROSIS; CASPASE-8; ACTIVATION; VISCERAL FAT; TNF-ALPHA;

D O I：

10.1093/lifemedi/lnac003

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Aging is a natural process that is characterized by chronic, low-grade inflammation, which represents the primary risk factor in the pathogenesis of a variety of diseases, i.e. aging-related diseases. RIP kinases, in particular RIPK1 and RIPK3, have emerged as master regulators of proinflammatory responses that act either by causing apoptosis and necroptosis or by directly regulating intracellular inflammatory signaling. While, RIPK1/3 and necroptosis are intimately linked to multiple human diseases, the relationship among RIPK1/3, necroptosis, and aging remains unclear. In this review, we discuss current evidence arguing for the involvement of RIPK1/3 and necroptosis in the progression of aging. In addition, we provide updated information and knowledge on the role of RIPK1/3 and necroptosis in aging-related diseases. Leveraging these new mechanistic insights in aging, we postulate how our improved understanding of RIPK1/3 and necroptosis in aging may support the development of therapeutics targeting RIPK1/3 and necroptosis for the modulation of aging and treatment of aging-related diseases.

引用

页码：2 / 20

页数：19

共 50 条

[41] Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
Javanmehr, Nima
Saleki, Kiarash
Alijanizadeh, Parsa
Rezaei, Nima
JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)
[42] Regulation and roles of RNA modifications in aging-related diseases
Jiapaer, Zeyidan
Su, Dingwen
Hua, Lingyang
Lehmann, Helge Immo
Gokulnath, Priyanka
Vulugundam, Gururaja
Song, Shannan
Zhang, Lingying
Gong, Ye
Li, Guoping
AGING CELL, 2022, 21 (07)
[43] Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases
Chen, Yao
Qi, Yongfen
Lu, Weiwei
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
[44] Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases
Zhuang, Wei
Yue, Lifeng
Dang, Xiaofang
Chen, Fei
Gong, Yuewen
Lin, Xiaolan
Luo, Yumin
AGING AND DISEASE, 2019, 10 (01): : 134 - 146
[45] A review on the role of RNA methylation in aging-related diseases
Wei, Hong
Xu, Yuhao
Lin, Li
Li, Yuefeng
Zhu, Xiaolan
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 254
[46] Gene Therapy Strategies Targeting Aging-Related Diseases
Yu, Jingyu
Li, Tianwen
Zhu, Jianhong
AGING AND DISEASE, 2023, 14 (02): : 398 - 417
[47] The Alteration of Subtelomeric DNA Methylation in Aging-Related Diseases
Hu, Haochang
Li, Bin
Duan, Shiwei
FRONTIERS IN GENETICS, 2019, 9
[48] Role of Antioxidants in the Protection from Aging-Related Diseases
Monti, Daria Maria
Rigano, Maria Manuela
Monti, Simona Maria
Peixoto, Herbenya Silva
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
[49] The connections of immune metabolic mechanisms with aging-related diseases
Tufanli, Ozlem
Citir, Mevlut
Yin, Changjun
van der Vorst, Emiel P. C.
Cimen, Ismail
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
[50] The Significance of 8-oxoGsn in Aging-Related Diseases
Zhang, Xinmu
Li, Lin
AGING AND DISEASE, 2020, 11 (05): : 1329 - 1338

← 1 2 3 4 5 →